Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Cash & Current Investments: 2017-2018

Historic Cash & Current Investments for Astria Therapeutics (ATXS) over the last 2 years, with Dec 2018 value amounting to $37.6 million.

  • Astria Therapeutics' Cash & Current Investments fell 6.07% to $40.6 million in Q3 2019 from the same period last year, while for Sep 2019 it was $176.0 million, marking a year-over-year increase of 39.02%. This contributed to the annual value of $37.6 million for FY2018, which is 129.52% up from last year.
  • Latest data reveals that Astria Therapeutics reported Cash & Current Investments of $37.6 million as of FY2018, which was up 129.52% from $16.4 million recorded in FY2017.
  • Astria Therapeutics' Cash & Current Investments' 5-year high stood at $37.6 million during FY2018, with a 5-year trough of $16.4 million in FY2017.
  • Over the past 2 years, Astria Therapeutics' median Cash & Current Investments value was $27.0 million (recorded in 2017), while the average stood at $27.0 million.
  • Data for Astria Therapeutics' Cash & Current Investments shows a peak YoY surged of 129.52% (in 2018) over the last 5 years.
  • Yearly analysis of 2 years shows Astria Therapeutics' Cash & Current Investments stood at $16.4 million in 2017, then soared by 129.52% to $37.6 million in 2018.